Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.71 |
| ▸ | S100B | P04271 | 3/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.70 |
| ▸ | MAPT | P10636 | 5/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.70 |
| ▸ | MEN1 | O00255 | 4/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.70 |
| ▸ | BLM | P54132 | 3/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | TP53 | P04637 | 2/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | POLB | P06746 | 2/20 | 0.70 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.70 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | CA1 | P00915 | 4/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15347676 | 1.00 | CA2 (0.71) | CA2S100BALDH1A1MAPTKMT2A | |
| SCHEMBL14373623 | 1.00 | CA2 (0.71) | CA2S100BALDH1A1MAPTKMT2A | |
| SCHEMBL11320970 | 1.00 | CA2 (0.71) | CA2S100BALDH1A1MAPTKMT2A | |
| SCHEMBL1033699 | 0.89 | CA2 (0.61) | CA2S100BALDH1A1MAPTKMT2A | |
| SCHEMBL2891275 | 0.89 | CA2 (0.61) | CA2S100BALDH1A1MAPTKMT2A | |
| SCHEMBL10045762 | 0.89 | CA2 (0.61) | CA2S100BALDH1A1MAPTKMT2A | |
| SCHEMBL11450591 | 0.89 | CA2 (0.61) | CA2S100BALDH1A1MAPTKMT2A | |
| SCHEMBL11458615 | 0.89 | S100B (0.66) | CA2S100BALDH1A1MAPTKMT2A | |
| SCHEMBL11458614 | 0.89 | S100B (0.66) | CA2S100BALDH1A1MAPTKMT2A | |
| SCHEMBL13780331 | 0.89 | CA2 (0.66) | CA2S100BALDH1A1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118812816-A | Flame-retardant nonionic waterborne polyurethane and preparation method thereof | 杭州传化精细化工有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118812815-A | Preparation method of phosphorus/silicon synergistic flame-retardant nonionic water-based polyurethane | 杭州传化精细化工有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-114573477-A | Resveratrol imine analogue and preparation method and application thereof | 西安医学院 | 2022-06-03 | — | — | CN | claimed |
| US-5421897-A | Applying liquid composition to surface contaminated with lead, solidifying into matrix which sequesters lead, removing matrix | GRAWE JOHN (US) | 1995-06-06 | — | — | US | claimed |
| CN-120535482-A | Schiff base epoxy oligomer chain extender, and preparation method and application thereof | 华南理工大学 | 2025-08-26 | — | — | CN | disclosed |
| CN-118812815-A | Preparation method of phosphorus/silicon synergistic flame-retardant nonionic water-based polyurethane | 杭州传化精细化工有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-118812816-A | Flame-retardant nonionic waterborne polyurethane and preparation method thereof | 杭州传化精细化工有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-118812816-A | Flame-retardant nonionic waterborne polyurethane and preparation method thereof | 杭州传化精细化工有限公司 | 2024-10-22 | — | — | CN | disclosed |
| US-12023660-B1 | Method of forming metal oxide nanostructures on a TiO2-ZnO-buffered substrate | King Faisal University (SA) | 2024-07-02 | — | — | US | disclosed |
| US-11980876-B1 | Method of forming metal oxide nanostructures on a TiO2—ZnO-buffered substrate | King Faisal University (SA) | 2024-05-14 | — | — | US | disclosed |
| US-11969720-B1 | Method of forming metal oxide nanostructures on a TiO2—ZnO-buffered substrate | King Faisal University (SA) | 2024-04-30 | — | — | US | disclosed |
| US-11964264-B1 | Method of forming metal oxide nanostructures on a TiO2-ZnO-buffered substrate | King Faisal University (SA) | 2024-04-23 | — | — | US | disclosed |
| US-4235929-A | TOPICAL ADMINISTRATION OF ANTIINFLAMMATORY AGENT | WILLIAM H. RORER, INC. (US) | 1980-11-25 | — | — | US | disclosed |
| US-4230727-A | N-BENZYLIDENEANILINE AND DERIVATIVES | WILLIAM H. RORER, INC. (US) | 1980-10-28 | — | — | US | disclosed |
| US-4211839-A | SILVER HALIDE AND ORGANIC SILVER SALT PREPARED IN AN IMINO COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1980-07-08 | — | — | US | disclosed |
| US-4198349-A | ANTIINFLAMMATORY, TOPICAL | WILLIAM H. RORER, INC. (US) | 1980-04-15 | — | — | US | disclosed |
| US-4188212-A | BEZNOTRIAZOLE | FUJI PHOTO FILM CO., LTD. (JP) | 1980-02-12 | — | — | US | disclosed |
| US-4187317-A | Sunscreen and erythema treating with N-benzylidene anilenes | WILLIAM H. RORER, INC. (US) | 1980-02-05 | — | — | US | disclosed |
| US-4176198-A | ANTIINFLAMMATORY AGENTS | WILLIAM H. RORER, INC. (US) | 1979-11-27 | — | — | US | disclosed |
| US-3933507-A | LIGHT INSENSITIVE SILVER SALT, POLYMETHINE SENSITIZER | AGFA-GEVAERT, A.G. (DT) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12023660-B1 | Method of forming metal oxide nanostructures on a TiO2-ZnO-buffered substrate | SOD1, AOC3, AOC2 | CA2 993/4885S100B 1294/4885ALDH1A1 137/4885 |
| US-11980876-B1 | Method of forming metal oxide nanostructures on a TiO2—ZnO-buffered substrate | SOD1, AOC3, AOC2 | CA2 899/4885S100B 1288/4885ALDH1A1 137/4885 |
| US-11964264-B1 | Method of forming metal oxide nanostructures on a TiO2-ZnO-buffered substrate | SOD1, AOC3, AOC2 | CA2 993/4885S100B 1294/4885ALDH1A1 137/4885 |
| US-11969720-B1 | Method of forming metal oxide nanostructures on a TiO2—ZnO-buffered substrate | SOD1, AOC3, AOC2 | CA2 899/4885S100B 1288/4885ALDH1A1 137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.